Searchable abstracts of presentations at key conferences in endocrinology

ea0070aep71 | Adrenal and Cardiovascular Endocrinology | ECE2020

Cardiovascular risk and metabolic profile in adult patients with congenital adrenal hyperplasia

Barbot Mattia , Ceccato Filippo , Patelli Ilaria , Regazzo Daniela , Lizzul Laura , Scaroni Carla

Background: Classic congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is characterized by impaired cortisol synthesis, requiring life-long glucocorticoid (GC) replacement therapy. Given the detrimental systemic effects of GCs in the long term, the aim of our study was to assess whether CAH patients have increased metabolic and cardiovascular alterations compared with age-matched controls.Materials and methods: For this cross-sectional...

ea0016p91 | Bone and calcium | ECE2008

Determinants of spinal deformities in adult patients with untreated growth hormone deficiency (GHD)

Mazziotti Gherardo , Bianchi Antonio , Bonadonna Stefania , Cimino Vincenzo , Fusco Alessandra , Patelli Ilaria , De Marinis Laura , Giustina Andrea

Adult GHD patients may have reduced BMD with high risk of vertebral and non-vertebral fractures which is thought to be reverted by long-term rhGH replacement therapy. In this study we aimed at identifying the determinant factors of vertebral fractures, as assessed by a radiological morphometric approach, in a cohort of adult patients with untreated GHD. Forty-two patients (27 males, 15 females; median age: 48 years, range: 30–67) with untreated severe (as defined by a pea...

ea0022p93 | Bone/Calcium | ECE2010

Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency

Mazziotti Gherardo , Porcelli Teresa , Bianchi Antonio , Cimino Vincenzo , Mejia Carola , Patelli Ilaria , Fusco Alessandra , Giampietro Antonella , De Marinis Laura , Giustina Andrea

GH deficiency (GHD) and excess of glucocorticoids are associated with increased risk of fragility fractures. Most adult GHD patients have other pituitary deficiencies, but it is unclear whether these deficiencies or their overreplacement therapies may influence the bone disease occurring in GHD. The aim of this study was to evaluate whether the prevalence of vertebral fractures may be influenced by glucocorticoid replacement therapy in hypopituitary males with GHD. We studied ...